vs
Side-by-side financial comparison of Frontdoor, Inc. (FTDR) and Bio-Techne (TECH). Click either name above to swap in a different company.
Frontdoor, Inc. is the larger business by last-quarter revenue ($451.0M vs $295.9M, roughly 1.5× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 9.1%, a 3.8% gap on every dollar of revenue. On growth, Frontdoor, Inc. posted the faster year-over-year revenue change (5.9% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -8.8%).
Frontdoor, Inc. operates a leading U.S.-focused home services and protection platform. It offers customizable home warranty plans covering repairs and replacements for household appliances, HVAC, plumbing, and electrical systems, plus on-demand access to a network of pre-vetted local service professionals for residential maintenance and repairs.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
FTDR vs TECH — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $451.0M | $295.9M |
| Net Profit | $41.0M | $38.0M |
| Gross Margin | 55.0% | 64.6% |
| Operating Margin | — | 18.4% |
| Net Margin | 9.1% | 12.8% |
| Revenue YoY | 5.9% | -6.4% |
| Net Profit YoY | 10.8% | 68.3% |
| EPS (diluted) | $0.57 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $451.0M | — | ||
| Q4 25 | $432.0M | $295.9M | ||
| Q3 25 | $618.0M | — | ||
| Q2 25 | $617.0M | $317.0M | ||
| Q1 25 | $426.0M | $316.2M | ||
| Q4 24 | $383.0M | $297.0M | ||
| Q3 24 | $540.0M | $289.5M | ||
| Q2 24 | $542.0M | $306.1M |
| Q1 26 | $41.0M | — | ||
| Q4 25 | $1.0M | $38.0M | ||
| Q3 25 | $106.0M | — | ||
| Q2 25 | $111.0M | $-17.7M | ||
| Q1 25 | $37.0M | $22.6M | ||
| Q4 24 | $9.0M | $34.9M | ||
| Q3 24 | $100.0M | $33.6M | ||
| Q2 24 | $92.0M | $40.6M |
| Q1 26 | 55.0% | — | ||
| Q4 25 | 49.3% | 64.6% | ||
| Q3 25 | 57.1% | — | ||
| Q2 25 | 57.7% | 62.7% | ||
| Q1 25 | 55.2% | 67.9% | ||
| Q4 24 | 48.0% | 65.3% | ||
| Q3 24 | 56.7% | 63.2% | ||
| Q2 24 | 56.5% | 66.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 18.4% | ||
| Q3 25 | 23.0% | — | ||
| Q2 25 | 23.7% | -7.5% | ||
| Q1 25 | 11.3% | 12.2% | ||
| Q4 24 | 1.6% | 16.0% | ||
| Q3 24 | 24.8% | 13.8% | ||
| Q2 24 | 22.9% | 15.0% |
| Q1 26 | 9.1% | — | ||
| Q4 25 | 0.2% | 12.8% | ||
| Q3 25 | 17.2% | — | ||
| Q2 25 | 18.0% | -5.6% | ||
| Q1 25 | 8.7% | 7.1% | ||
| Q4 24 | 2.3% | 11.7% | ||
| Q3 24 | 18.5% | 11.6% | ||
| Q2 24 | 17.0% | 13.3% |
| Q1 26 | $0.57 | — | ||
| Q4 25 | $0.03 | $0.24 | ||
| Q3 25 | $1.42 | — | ||
| Q2 25 | $1.48 | $-0.11 | ||
| Q1 25 | $0.49 | $0.14 | ||
| Q4 24 | $0.10 | $0.22 | ||
| Q3 24 | $1.30 | $0.21 | ||
| Q2 24 | $1.18 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $603.0M | $172.9M |
| Total DebtLower is stronger | $1.2B | $260.0M |
| Stockholders' EquityBook value | $230.0M | $2.0B |
| Total Assets | $2.2B | $2.5B |
| Debt / EquityLower = less leverage | 5.07× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $603.0M | — | ||
| Q4 25 | $566.0M | $172.9M | ||
| Q3 25 | $563.0M | — | ||
| Q2 25 | $562.0M | $162.2M | ||
| Q1 25 | $506.0M | $140.7M | ||
| Q4 24 | $436.0M | $177.5M | ||
| Q3 24 | $375.0M | $187.5M | ||
| Q2 24 | $419.0M | $152.9M |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.1B | $260.0M | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | $346.0M | ||
| Q1 25 | $1.2B | $330.0M | ||
| Q4 24 | $1.2B | $300.0M | ||
| Q3 24 | $565.0M | $300.0M | ||
| Q2 24 | $569.0M | $319.0M |
| Q1 26 | $230.0M | — | ||
| Q4 25 | $242.0M | $2.0B | ||
| Q3 25 | $316.0M | — | ||
| Q2 25 | $254.0M | $1.9B | ||
| Q1 25 | $198.0M | $2.0B | ||
| Q4 24 | $239.0M | $2.1B | ||
| Q3 24 | $261.0M | $2.1B | ||
| Q2 24 | $214.0M | $2.1B |
| Q1 26 | $2.2B | — | ||
| Q4 25 | $2.1B | $2.5B | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $2.2B | $2.6B | ||
| Q1 25 | $2.1B | $2.6B | ||
| Q4 24 | $2.1B | $2.7B | ||
| Q3 24 | $1.2B | $2.7B | ||
| Q2 24 | $1.2B | $2.7B |
| Q1 26 | 5.07× | — | ||
| Q4 25 | 4.73× | 0.13× | ||
| Q3 25 | 3.64× | — | ||
| Q2 25 | 4.56× | 0.18× | ||
| Q1 25 | 5.88× | 0.16× | ||
| Q4 24 | 4.90× | 0.14× | ||
| Q3 24 | 2.16× | 0.14× | ||
| Q2 24 | 2.66× | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | — |
| Free Cash FlowOCF − Capex | $114.0M | — |
| FCF MarginFCF / Revenue | 25.3% | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $387.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $101.0M | — | ||
| Q3 25 | $64.0M | — | ||
| Q2 25 | $127.0M | $98.2M | ||
| Q1 25 | $124.0M | $41.1M | ||
| Q4 24 | $58.0M | $84.3M | ||
| Q3 24 | $25.0M | $63.9M | ||
| Q2 24 | $103.0M | $75.5M |
| Q1 26 | $114.0M | — | ||
| Q4 25 | $95.0M | — | ||
| Q3 25 | $58.0M | — | ||
| Q2 25 | $120.0M | $93.3M | ||
| Q1 25 | $117.0M | $31.0M | ||
| Q4 24 | $50.0M | $77.5M | ||
| Q3 24 | $16.0M | $54.7M | ||
| Q2 24 | $91.0M | $57.5M |
| Q1 26 | 25.3% | — | ||
| Q4 25 | 22.0% | — | ||
| Q3 25 | 9.4% | — | ||
| Q2 25 | 19.4% | 29.4% | ||
| Q1 25 | 27.5% | 9.8% | ||
| Q4 24 | 13.1% | 26.1% | ||
| Q3 24 | 3.0% | 18.9% | ||
| Q2 24 | 16.8% | 18.8% |
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 1.1% | 1.5% | ||
| Q1 25 | 1.6% | 3.2% | ||
| Q4 24 | 2.1% | 2.3% | ||
| Q3 24 | 1.7% | 3.2% | ||
| Q2 24 | 2.2% | 5.9% |
| Q1 26 | — | — | ||
| Q4 25 | 101.00× | — | ||
| Q3 25 | 0.60× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 3.35× | 1.82× | ||
| Q4 24 | 6.44× | 2.42× | ||
| Q3 24 | 0.25× | 1.90× | ||
| Q2 24 | 1.12× | 1.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FTDR
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
